COMMODORE CAPITAL LP 13D and 13G filings for CymaBay Therapeutics, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2024-02-14 4:05 pm Sale | 2023-12-31 | 13G | CymaBay Therapeutics, Inc. CBAY | COMMODORE CAPITAL LP | 0 0.000% | -5,738,500 (Position Closed) | Filing |
| 2023-02-14 4:06 pm Purchase | 2022-12-31 | 13G | CymaBay Therapeutics, Inc. CBAY | COMMODORE CAPITAL LP | 5,738,500 6.800% | 318,604 (+5.88%) | Filing |
| 2022-02-14 4:08 pm Purchase | 2021-12-31 | 13G | CymaBay Therapeutics, Inc. CBAY | COMMODORE CAPITAL LP | 5,419,896 7.800% | 1,890,431 (+53.56%) | Filing |
| 2021-07-12 2:44 pm Purchase | 2021-06-30 | 13G | CymaBay Therapeutics, Inc. CBAY | COMMODORE CAPITAL LP | 3,529,465 5.100% | 3,529,465 (New Position) | Filing |